---
title: "TELEMAN DAN BENJAMIN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/08da5a73-af7a-5f3f-91b4-bb38fe847fc0
json: https://whiteintel.dev/api/public/dossier/08da5a73-af7a-5f3f-91b4-bb38fe847fc0
identifier: sec:0002122500
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# TELEMAN DAN BENJAMIN

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0002122500`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/08da5a73-af7a-5f3f-91b4-bb38fe847fc0  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/08da5a73-af7a-5f3f-91b4-bb38fe847fc0  

## Ownership & control

### Holdings / subsidiaries

- **NASUS PHARMA LTD** (officer) — https://whiteintel.dev/entity/0ff4ba8b-bcbf-503a-b4ad-7080fa5bafdf
- **NASUS PHARMA LTD** (director) — https://whiteintel.dev/entity/0ff4ba8b-bcbf-503a-b4ad-7080fa5bafdf

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **TELEMAN DAN BENJAMIN**. Human view: https://whiteintel.dev/entity/08da5a73-af7a-5f3f-91b4-bb38fe847fc0 · Structured JSON: https://whiteintel.dev/api/public/dossier/08da5a73-af7a-5f3f-91b4-bb38fe847fc0._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._